A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

Conditions: Diabetic Retinopathy
Interventions: Drug: BI 764524; Drug: Sham comparator to BI 764524; Drug: Aflibercept (Eylea®) – US only
Sponsors: Boehringer Ingelheim
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 23, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments